【Blood-Based Protein Biomarkers for Alzheimer’s Disease: Diagnostic and Mechanistic Insights】   To connect medical professionals in genetics and genomics, we have been organising a series of thematic seminars under the GENE Club — a platform for clinicians, scientists, and researchers to exchange knowledge, foster collaboration, and nurture excellence in genomic medicine.   In the latest session, we were delighted to welcome Prof Amy Fu Kit-yu, who explored how blood-based biomarkers and artificial intelligence are opening new possibilities for earlier detection, disease staging and treatment monitoring in Alzheimer’s disease. 🧪   🎤 Topic: Blood-Based Protein Biomarkers for Alzheimer’s Disease: Diagnostic and Mechanistic Insights 👩🏻‍⚕️Speakers: Prof Amy Fu Kit-yu Research Professor, Division of Life Science, The Hong Kong University of Science and Technology 📽️ Watch the seminar here: https://lnkd.in/g5fNZZBs   {hashtag|#|HKGI} {hashtag|#|HKGP} {hashtag|#|HongKongGenomeInstitute} {hashtag|#|GenomicMedicine} {hashtag|#|GenomeProject} {hashtag|#|GENEClub} {hashtag|#|KnowledgeSharing} {hashtag|#|AlzheimersDisease} {hashtag|#|Biomarkers} {hashtag|#|ArtificialIntelligence}

【Behind the Green Level: HKGI's Green Lab Certificate🌱🔬】   Every sustainable lab starts with everyday actions. 👩🏻‍🔬✨   Building on our earlier sharing, we are excited to share that HKGI’s genomic laboratory has achieved the Green Level of the internationally recognised My Green Lab Certification programme, which is the highest-tier and most prestigious ranking in the programme. 🎉   To mark this achievement, we have created a video showcasing how sustainability is embedded in our daily laboratory operations, from smart inventory management and waste reduction to resource conservation and other everyday green practices.   These small but meaningful actions reflect our ongoing efforts to create a more sustainable laboratory environment.   Watch the video to learn more about the efforts behind our green lab journey. 💚   {hashtag|#|HKGI} {hashtag|#|HKGP} {hashtag|#|MyGreenLab} {hashtag|#|Sustainability} {hashtag|#|SustainableScience} {hashtag|#|GenomicMedicine} {hashtag|#|ScientificResearch}

【HKGI-APSHG Distinguished Scholar Lectures: The Presidential Series | Developing Drugs to Target RNA Splice Mutations】   Could the next breakthrough in genomic medicine lie in targeting RNA splice mutations? 🧬✨   Organised in partnership with the Asia Pacific Society of Human Genetics (APSHG), the series brings together presidents of leading human genetics societies worldwide to share leadership perspectives and international developments shaping the future of genomic medicine. 🌟   For the fourth lecture, we are pleased to welcome Prof Susan A. Slaugenhaupt, PhD, President of The American Society of Human Genetics, who will speak on “Developing Drugs to Target RNA Splice Mutations”, exploring how new medicines are being developed to tackle RNA splicing mutations in genetic diseases.   🗣️ Speaker: Prof Susan A. Slaugenhaupt, PhD, President, The American Society of Human Genetics 🎤 Lecture Topic: Developing Drugs to Target RNA Splice Mutations 📅 Date: 28 Oct 2026 (Wed) | Time: 8:00-9:00pm (HKT) 🔗 Register now: https://lnkd.in/gerckiGU   Join us for this insightful session!   ✅  𝐂𝐌𝐄 𝐚𝐜𝐜𝐫𝐞𝐝𝐢𝐭𝐚𝐭𝐢𝐨𝐧 𝐜𝐨𝐧𝐟𝐢𝐫𝐦𝐞𝐝 𝐛𝐲 𝐇𝐨𝐧𝐠 𝐊𝐨𝐧𝐠 𝐂𝐨𝐥𝐥𝐞𝐠𝐞 𝐨𝐟 𝐂𝐨𝐦𝐦𝐮𝐧𝐢𝐭𝐲 𝐌𝐞𝐝𝐢𝐜𝐢𝐧𝐞, 𝐇𝐨𝐧𝐠 𝐊𝐨𝐧𝐠 𝐂𝐨𝐥𝐥𝐞𝐠𝐞 𝐨𝐟 𝐏𝐬𝐲𝐜𝐡𝐢𝐚𝐭𝐫𝐢𝐬𝐭𝐬, 𝐇𝐨𝐧𝐠 𝐊𝐨𝐧𝐠 𝐂𝐨𝐥𝐥𝐞𝐠𝐞 𝐨𝐟 𝐑𝐚𝐝𝐢𝐨𝐥𝐨𝐠𝐢𝐬𝐭𝐬, 𝐌𝐞𝐝𝐢𝐜𝐚𝐥 𝐂𝐨𝐮𝐧𝐜𝐢𝐥 𝐨𝐟 𝐇𝐨𝐧𝐠 𝐊𝐨𝐧𝐠, 𝐓𝐡𝐞 𝐂𝐨𝐥𝐥𝐞𝐠𝐞 𝐨𝐟 𝐎𝐩𝐡𝐭𝐡𝐚𝐥𝐦𝐨𝐥𝐨𝐠𝐢𝐬𝐭𝐬 𝐨𝐟 𝐇𝐨𝐧𝐠 𝐊𝐨𝐧𝐠, 𝐓𝐡𝐞 𝐂𝐨𝐥𝐥𝐞𝐠𝐞 𝐨𝐟 𝐒𝐮𝐫𝐠𝐞𝐨𝐧𝐬 𝐨𝐟 𝐇𝐨𝐧𝐠 𝐊𝐨𝐧𝐠, 𝐓𝐡𝐞 𝐇𝐨𝐧𝐠 𝐊𝐨𝐧𝐠 𝐂𝐨𝐥𝐥𝐞𝐠𝐞 𝐨𝐟 𝐀𝐧𝐚𝐞𝐬𝐭𝐡𝐞𝐬𝐢𝐨𝐥𝐨𝐠𝐢𝐬𝐭𝐬, 𝐓𝐡𝐞 𝐇𝐨𝐧𝐠 𝐊𝐨𝐧𝐠 𝐂𝐨𝐥𝐥𝐞𝐠𝐞 𝐨𝐟 𝐄𝐦𝐞𝐫𝐠𝐞𝐧𝐜𝐲 𝐌𝐞𝐝𝐢𝐜𝐢𝐧𝐞, 𝐓𝐡𝐞 𝐇𝐨𝐧𝐠 𝐊𝐨𝐧𝐠 𝐂𝐨𝐥𝐥𝐞𝐠𝐞 𝐨𝐟 𝐅𝐚𝐦𝐢𝐥𝐲 𝐏𝐡𝐲𝐬𝐢𝐜𝐢𝐚𝐧𝐬, 𝐓𝐡𝐞 𝐇𝐨𝐧𝐠 𝐊𝐨𝐧𝐠 𝐂𝐨𝐥𝐥𝐞𝐠𝐞 𝐨𝐟 𝐎𝐛𝐬𝐭𝐞𝐭𝐫𝐢𝐜𝐢𝐚𝐧𝐬 𝐚𝐧𝐝 𝐆𝐲𝐧𝐚𝐞𝐜𝐨𝐥𝐨𝐠𝐢𝐬𝐭𝐬, 𝐓𝐡𝐞 𝐇𝐨𝐧𝐠 𝐊𝐨𝐧𝐠 𝐂𝐨𝐥𝐥𝐞𝐠𝐞 𝐨𝐟 𝐎𝐫𝐭𝐡𝐨𝐩𝐚𝐞𝐝𝐢𝐜 𝐒𝐮𝐫𝐠𝐞𝐨𝐧𝐬, 𝐓𝐡𝐞 𝐇𝐨𝐧𝐠 𝐊𝐨𝐧𝐠 𝐂𝐨𝐥𝐥𝐞𝐠𝐞 𝐨𝐟 𝐎𝐭𝐨𝐫𝐡𝐢𝐧𝐨𝐥𝐚𝐫𝐲𝐧𝐠𝐨𝐥𝐨𝐠𝐢𝐬𝐭𝐬, 𝐓𝐡𝐞 𝐇𝐨𝐧𝐠 𝐊𝐨𝐧𝐠 𝐂𝐨𝐥𝐥𝐞𝐠𝐞 𝐨𝐟 𝐏𝐚𝐞𝐝𝐢𝐚𝐭𝐫𝐢𝐜𝐢𝐚𝐧𝐬, 𝐓𝐡𝐞 𝐇𝐨𝐧𝐠 𝐊𝐨𝐧𝐠 𝐂𝐨𝐥𝐥𝐞𝐠𝐞 𝐨𝐟 𝐏𝐚𝐭𝐡𝐨𝐥𝐨𝐠𝐢𝐬𝐭𝐬, 𝐓𝐡𝐞 𝐇𝐨𝐧𝐠 𝐊𝐨𝐧𝐠 𝐂𝐨𝐥𝐥𝐞𝐠𝐞 𝐨𝐟 𝐏𝐡𝐲𝐬𝐢𝐜𝐢𝐚𝐧𝐬; 𝐚𝐝𝐝𝐢𝐭𝐢𝐨𝐧𝐚𝐥 𝐚𝐩𝐩𝐫𝐨𝐯𝐚𝐥𝐬 𝐚𝐫𝐞 𝐩𝐞𝐧𝐝𝐢𝐧𝐠.   {hashtag|#|HKGI} {hashtag|#|HKGP} {hashtag|#|HongKongGenomeProject} {hashtag|#|GenomicMedicine} {hashtag|#|APSHG} {hashtag|#|PresidentialSeries} {hashtag|#|DrugDevelopment} {hashtag|#|GeneticDiseases} {hashtag|#|HumanGenetics}

【🎯𝗗𝗼𝗻'𝘁 𝗠𝗶𝘀𝘀 𝗛𝗞𝗚𝗜'𝘀 𝗦𝗲𝘀𝘀𝗶𝗼𝗻 𝗮𝘁 𝘁𝗵𝗲 𝗖𝗔𝗥𝗘 𝗦𝘂𝗺𝗺𝗶𝘁 𝟮𝟬𝟮𝟲 𝗼𝗻 𝟰 𝗡𝗼𝘃 – 𝗥𝗲𝗴𝗶𝘀𝘁𝗲𝗿 𝗡𝗼𝘄】   We are excited to be part of the Clinical Advancement and Research Excellence Summit (CARE Summit) 2026, hosted by the Greater Bay Area International Clinical Trial Institute (GBAICTI), on 4 November 2026 at the Hong Kong Convention and Exhibition Centre.   As part of the conference, we will host 𝗧𝗿𝗮𝗰𝗸 𝟮: 𝗚𝗲𝗻𝗼𝗺𝗶𝗰𝘀 𝗮𝗻𝗱 𝗥𝗮𝗿𝗲 𝗗𝗶𝘀𝗲𝗮𝘀𝗲, bringing together leading experts from around the world to discuss the future of genomic medicine. ✨   Under the theme “𝗔𝗱𝘃𝗮𝗻𝗰𝗲𝗱 𝗧𝗵𝗲𝗿𝗮𝗽𝗶𝗲𝘀 𝗮𝗻𝗱 𝗚𝗲𝗻𝗼𝗺𝗶𝗰-𝗜𝗻𝗳𝗼𝗿𝗺𝗲𝗱 𝗧𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁: 𝗔 𝗚𝗹𝗼𝗯𝗮𝗹 𝗣𝗲𝗿𝘀𝗽𝗲𝗰𝘁𝗶𝘃𝗲 𝗳𝗿𝗼𝗺 𝗕𝗲𝗻𝗰𝗵 𝘁𝗼 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗧𝗿𝗶𝗮𝗹”, distinguished speakers will share the latest developments in gene therapies, genomic technologies, precision medicine, and novel treatment approaches. Through presentations and discussions, you will gain insights into how cutting-edge research is being translated into clinical applications and improved outcomes for individuals with rare and genetic diseases. 💭🧬   📅 Date: 4 November 2026 | Time: 2:00pm – 5:15pm (HKT) 📍 Venue: S420 Series Rooms, Level 4, Hong Kong Convention and Exhibition Centre, Wan Chai, Hong Kong 🎟️ Admission: Free of charge (first come, first served) 👥 Format: Physical attendance 📖 Speaker Synopses: https://lnkd.in/gsvR-7zP 🔗 Register now: https://lnkd.in/gg7fkg\_M   Join us for an afternoon of thought-provoking discussion and knowledge exchange! {hashtag|#|HKGI} {hashtag|#|HKGP} {hashtag|#|HongKongGenomeInstitute} {hashtag|#|GenomicMedicine} {hashtag|#|GenomeProject} {hashtag|#|CARESummit2026} {hashtag|#|GBAICTI} {hashtag|#|HKConference} {hashtag|#|ClinicalTrials}

【📣Genetics & Genomics Conference 2026】   We are pleased to co-organise the Genetics & Genomics Conference 2026 with the Hong Kong Academy of Medicine, bringing together renowned overseas and local speakers to explore the latest developments and applications of genomic medicine. ✨   The conference will cover areas including Newborn Genome Screening, Reproductive Genetics and Genomics, Genetics and Therapeutics, and Cancer-related Genetics. It will also provide a platform for meaningful exchange on the ethical, clinical and practical considerations of integrating genomics into routine healthcare. 🌐⚕️   We look forward to welcoming healthcare professionals, researchers and partners to join the discussion and exchange insights on these important topics shaping the future of genomic medicine.   📅 Date: 31 Oct 2026 (Sat) | Time: 9:00 -15:50 (HKT) 👥 Format: Face-to-Face 📍 Venue: Pao Yue Kong Auditorium, G/F, Hong Kong Academy of Medicine Jockey Club Building, 99 Wong Chuk Hang Road, Aberdeen, Hong Kong 📝 Registration deadline: 21 Oct 2026 (Wed)   ➡️Register Now: https://lnkd.in/g8Tw8Pf9   {hashtag|#|HKGI} {hashtag|#|HKGP} {hashtag|#|HongKongGenomeInstitute} {hashtag|#|GenomeProject} {hashtag|#|HKAM} {hashtag|#|GeneticsAndGenomicsConference2026} {hashtag|#|Conference}

【Global Health Summit 2026 ⚕️】 Advancing genomics requires strong collaboration across research, clinical practice and innovation ecosystems. With this in mind, our Chief Executive Officer, Dr Hon-Yin Brian Chung, joined the Global Health Summit 2026, as a panellist in the discussion “From Genomics to Clinical Trials: Building a Greater Bay Area Collaboration Network”. 👥 💬 Co-moderated by Prof Aya El Helali and Dr Peter Woo (胡日明), the panel brought together Dr Chung, Prof Gilberto K.K. Leung and Prof Yonggao Mou to exchange views on strengthening collaboration across genomics, clinical trials and healthcare innovation in the Greater Bay Area. These exchanges reflected HKGI’s focus on working with partners to bring genomic insights closer to patient care. We look forward to continued collaboration across the region. 🌐 ✨ {hashtag|#|HKGI} {hashtag|#|HKGP} {hashtag|#|HongKongGenomeInstitute} {hashtag|#|GenomicMedicine} {hashtag|#|GenomeProject} {hashtag|#|GlobalHealthSummit2026} {hashtag|#|GreaterBayArea} {hashtag|#|ClinicalResearch} {hashtag|#|ClinicalTrials}